The healthcare institution and life-sciences technology platform are working together to use artificial intelligence to detect and understand the virus.
The company is putting artificial intelligence to work in the hopes of coming up with more precise, effective tests and therapies for a range of diseases.
The technology, developed by life-sciences software firm Deep Lens, integrates cancer genetic data into an advanced platform to connect patients with studies and treatments.
Produced by clinical trial software firm Florence Healthcare, the awards program seeks to recognize the contribution research professionals make to the industry.
The open-access resource, funded in part by the Bill and Melinda gates Foundation, is available to researchers, clinicians and others working on a cure.
A research team including MIT, Harvard and Stanford researchers has raised $20m in seed funding for their effort to map out immune cells with machine learning.
A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.
The federal agency continues to offer advice for healthcare and pharma industry professionals, and to take action against companies acting out of bounds.
The company’s global analysis from thousands of studies and sites indicates dramatic shifts in enrollment across several countries since the pandemic began.
Led by Medable, the multi-company effort is geared toward ramping up development of treatments, diagnostics and other solutions for the pandemic-causing virus.
The health data specialists look at real-world evidence and real-world data, and how clinical trial sites and sponsors can make the best use of such information tools.
The EndPandemic National Data Consortium has grown to six life-sciences and information-technology organizations, joining to collaborate on research data.
